Today's intel, medical breakthrough: An artificial blood company is seeking investment, and investing in this company now is an opportunity.
Contact information for relevant personnel is attached on the second page.
Is it really an investment opportunity with a pharmaceutical company?
Having read this, Chen Yiyang was very curious. This was his first time encountering an investment opportunity in this industry.
Based on the relevant information he had seen before.
Currently, the domestic pharmaceutical companies are many and chaotic; although there are quite a number of private enterprises, most large private pharmaceutical companies primarily focus on the production and sale of generic drugs.
The small ones are purely a pandemonium, with hardly any capable ones.
So, after collecting information, Chen Yiyang's investment company assistant suggested not investing in this industry.
